BMY Covered Call Strategy
BMY (Bristol-Myers Squibb Company), in the Healthcare sector, (Drug Manufacturers - General industry), listed on NYSE.
Bristol-Myers Squibb Company operates as a global biopharmaceutical entity, actively involved in the research, development, licensing, production, and worldwide commercialization of its medicinal portfolio. The company's therapeutic areas span hematology, oncology, cardiovascular health, immunology, fibrotic conditions, neuroscience, and infectious diseases like COVID-19. Its significant pharmaceutical offerings include Revlimid, an oral immunomodulatory agent for multiple myeloma, and Eliquis, an oral anticoagulant crucial for reducing stroke risk and systemic embolism in non-valvular atrial fibrillation, as well as treating deep vein thrombosis and pulmonary embolism. The portfolio also features Opdivo, utilized across various anti-cancer indications; Pomalyst/Imnovid, prescribed for multiple myeloma patients; and Orencia, targeting active rheumatoid arthritis and psoriatic arthritis in adults. Other key therapies are Sprycel, employed in the management of Philadelphia chromosome-positive chronic myeloid leukemia; Yervoy, indicated for patients with unresectable or metastatic melanoma; and Abraxane, a protein-bound chemotherapy formulation. Furthermore, Bristol-Myers Squibb offers Reblozyl, addressing anemia in adult patients with beta thalassemia; Empliciti, another treatment option for multiple myeloma; and Zeposia, designed to treat relapsing forms of multiple sclerosis.
BMY (Bristol-Myers Squibb Company) trades in the Healthcare sector, specifically Drug Manufacturers - General, with a market capitalization of approximately $130.12B, a trailing P/E of 14.01, a beta of 0.23 versus the broader market, a 52-week range of 42.52-68.1, average daily share volume of 11.7M, a public-listing history dating back to 1972, approximately 33K full-time employees. These structural characteristics shape how BMY stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.23 indicates BMY has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure. BMY pays a dividend, which adjusts put-call parity and shifts the ex-dividend pricing across the listed chain.
What is a covered call on BMY?
A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income.
BMY snapshot
As of August 14, 2026, spot at $63.97, ATM IV 24.73%, IV rank 20.20%, expected move 7.09%. The covered call on BMY below is built from the August 14, 2026 end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 28-day expiry.
Why this covered call structure on BMY specifically: BMY IV at 24.73% is on the cheap side of its 1-year range, which means a premium-selling BMY covered call collects less credit per unit of strike-width risk, with a market-implied 1-standard-deviation move of approximately 7.09% (roughly $4.54 on the underlying). The 28-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated BMY expiries trade a higher absolute premium for lower per-day decay. Position sizing on BMY should anchor to the underlying notional of $63.97 per share and to the trader's directional view on BMY stock.
BMY covered call setup
The BMY covered call below is built from the August 14, 2026 end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With BMY at $63.97 on that close, the first option leg uses a $67.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed BMY chain at a 28-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 BMY shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 100 shares | Stock | $63.97 | long |
| Sell 1 | Call | $67.00 | $0.70 |
BMY covered call risk and reward
- Net Premium / Debit
- -$6,327.50
- Max Profit (per contract)
- $372.50
- Max Loss (per contract)
- -$6,326.50
- Breakeven(s)
- $63.28
- Risk / Reward Ratio
- 0.059
Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium.
BMY covered call payoff curve
Modeled P&L at expiration across a range of underlying prices for the covered call on BMY. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -100.0% | -$6,326.50 |
| $14.15 | -77.9% | -$4,912.20 |
| $28.30 | -55.8% | -$3,497.90 |
| $42.44 | -33.7% | -$2,083.60 |
| $56.58 | -11.5% | -$669.29 |
| $70.73 | +10.6% | +$372.50 |
| $84.87 | +32.7% | +$372.50 |
| $99.01 | +54.8% | +$372.50 |
| $113.15 | +76.9% | +$372.50 |
| $127.30 | +99.0% | +$372.50 |
When traders use covered call on BMY
Covered calls on BMY are an income strategy run on existing BMY stock positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.
BMY thesis for this covered call
The market-implied 1-standard-deviation range for BMY extends from approximately $59.43 on the downside to $68.51 on the upside. A BMY covered call collects premium on an existing long BMY position, trading off upside above the short call strike for immediate income; the short strike selection should reflect the trader's view on whether BMY will breach that level within the expiration window. Current BMY IV rank near 20.20% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on BMY at 24.73%. As a Healthcare name, BMY options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to BMY-specific events.
BMY covered call positions are structurally neutral to slightly bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. BMY positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move BMY alongside the broader basket even when BMY-specific fundamentals are unchanged. Short-premium structures like a covered call on BMY carry tail risk when realized volatility exceeds the implied move; review historical BMY earnings reactions and macro stress periods before sizing. Always rebuild the position from current BMY chain quotes before placing a trade.
Frequently asked questions
- What is a covered call on BMY?
- A covered call on BMY is the covered call strategy applied to BMY (stock). The strategy is structurally neutral to slightly bullish: A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income. With BMY stock at $63.97 on the August 14, 2026 close, the strikes shown on this page are snapped to the nearest listed BMY chain strike and the premiums come straight from that session's bid/ask midpoint.
- How are BMY covered call max profit and max loss calculated?
- Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium. For the BMY covered call priced from the August 14, 2026 end-of-day chain at a 30-day expiry (ATM IV 24.73%), the computed maximum profit is $372.50 per contract and the computed maximum loss is -$6,326.50 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a BMY covered call?
- The breakeven for the BMY covered call priced on this page is roughly $63.28 at expiration, derived from the August 14, 2026 end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The BMY market-implied 1-standard-deviation expected move in the same options snapshot is approximately 7.09%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a covered call on BMY?
- Covered calls on BMY are an income strategy run on existing BMY stock positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.
- How does current BMY implied volatility affect this covered call?
- BMY ATM IV is at 24.73% with IV rank near 20.20%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.